Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection

Gut

Volumn 43, Issue 6, 1998, Pages 763-769

  Jeppesen, P B ^a   Staun, M ^a   Tjellesen, L ^a   Mortensen, P B ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Diarrhoea; Human; Omeprazole; Ranitidine; Short bowel syndrome

Indexed keywords

CALCIUM; CARBOHYDRATE; DIVALENT CATION; ELECTROLYTE; FAT; HISTAMINE H2 RECEPTOR ANTAGONIST; MAGNESIUM; NITROGEN; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; SODIUM; WATER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY ABSORPTION; FECES; FEMALE; HUMAN; INTESTINE ABSORPTION; INTESTINE RESECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUTRIENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT BOWEL SYNDROME; SODIUM ABSORPTION; WATER ABSORPTION;

EID: 0031769533     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.6.763     Document Type: Article

References (22)

1. Ladefoged K. Quality of life in patients on permanent home parenteral nutrition. J Parenter Enteral Nutr 1981;5:132-7.
2. O'Hanrahan T, Irving MH. The role of home parenteral nutrition in the management of intestinal failure - report of 400 cases. Clin Nutr 1992;11:331-6.
3. Buxton B. Small bowel resection and gastric acid hypersecretion. Gut 1974;15:229-38.
4. Malagelada JR. Pathophysiological responses to meals in the Zollinger-Ellison syndrome: 2. Gastric emptying and its effect on duodenal function. Gut 1980;21:98-104.
5. Heizer WD, Cleveland CR, Iber FL. Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 1965;116: 261-5.
6. Go VL, Poley JR, Hofmann AF, et al. Disturbances in fat digestion induced by acidic jejunal pH due to gastric hypersecretion in man. Gastroenterology 1970;58:638-46.
7. Nightingale JM, Walker ER, Farthing MJ, et al. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991;5:405-12.
8. Jacobsen O, Ladefoged K, Stage JG, et al. Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol 1986;21:824-8.
9. Cortot A, Fleming CR, Malagelada JR. Improved nutrient absorption after cimetidine in short-bowel syndrome with gastric hypersecretion. N Engl J Med 1979;300:79-80.
10. Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985;313:70-3.
11. Bo Linn GW, Davis GR, Buddrus DJ, et al. An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 1984;73:640-7.
12. AOAC. AOAC official methods of analysis. Arlington: AOAC Inc., 1984.
13. Englyst HN, Cummings JH. Non-starch polysaccharides (dietary fiber) and resistant starch. Adv Exp Med Biol 1990; 270:205-25.
14. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600-8.
15. Thomas PJ. Identification of some enteric bacteria which convert oleic acid to hydroxystearic acid in vitro. Gastroenterology 1972;62:430-5.
16. Soong CS, Thompson JB, Poley JR, et al. Hydroxy fatty acids in human diarrhea. Gastroenterology 1972;63:748-57.
17. Webb JPW, James AT, Kellock TD. The influence of diet on the quality of faecal fat in patients with and without steatorrhoea. Gut 1963;4:37-41.
18. Southgate DA, Durnin JV. Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets. Br J Nutr 1970; 24:517-35.
19. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39(suppl 1):5-41.
20. 2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn's disease. Acta Med Scand 1980;207: 119-22.
21. 2-receptor vasodilation of canine intestinal circulation. Am J Physiol 1977;233:E219-24.
22. Houben GM, Hooi J, Hameeteman W, et al. Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo. Aliment Pharmacol Ther 1995;9:649-54.